Clinical Trial Update: Adoptive Transfer of Haplo-identical DLI for AML and MDS [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for adoptive transfer of haplo-identical donor lymphocyte infusion in AML and MDS, completed with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• haplo-identical donor lymphocyte infusion (haplo-identical DLI)

Snippet

Sponsor: Duke University | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-07-18